Balchem Stock Buy Hold or Sell Recommendation
| BCPC Stock | USD 178.03 0.50 0.28% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Balchem is 'Hold'. Macroaxis provides Balchem buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Balchem positions.
Check out Balchem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide. In addition, we conduct extensive research on individual companies such as Balchem and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Balchem |
Execute Balchem Buy or Sell Advice
The Balchem recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Balchem. Macroaxis does not own or have any residual interests in Balchem or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Balchem's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Balchem Trading Alerts and Improvement Suggestions
| Balchem has a strong financial position based on the latest SEC filings | |
| Over 91.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Balchem Co. Shares Acquired by Victory Capital Management Inc. - MarketBeat |
Balchem Returns Distribution Density
The distribution of Balchem's historical returns is an attempt to chart the uncertainty of Balchem's future price movements. The chart of the probability distribution of Balchem daily returns describes the distribution of returns around its average expected value. We use Balchem price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Balchem returns is essential to provide solid investment advice for Balchem.
| Mean Return | 0.11 | Value At Risk | -1.99 | Potential Upside | 2.64 | Standard Deviation | 1.48 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Balchem historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Balchem Stock Institutional Investors
| Shares | Clearbridge Advisors, Llc | 2024-06-30 | 452.3 K | Jpmorgan Chase & Co | 2024-06-30 | 451.3 K | Ameriprise Financial Inc | 2024-06-30 | 431 K | Schroder Investment Management Group | 2024-06-30 | 418.3 K | Norges Bank | 2024-06-30 | 387.5 K | Northern Trust Corp | 2024-09-30 | 371.9 K | Charles Schwab Investment Management Inc | 2024-09-30 | 362 K | Congress Asset Management Company, Llp | 2024-09-30 | 301.4 K | Stephens Inv Mgmt Group Llc | 2024-09-30 | 281.5 K | Blackrock Inc | 2024-06-30 | 4.9 M | Vanguard Group Inc | 2024-09-30 | 3.9 M |
Balchem Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (11.4M) | 13.9M | (21.0M) | (7.8M) | 10.5M | 11.1M | |
| Free Cash Flow | 96.0M | 116.7M | 123.1M | 88.2M | 145.9M | 153.2M | |
| Depreciation | 45.9M | 51.3M | 48.9M | 51.8M | 54.9M | 57.7M | |
| Capital Expenditures | 28.4M | 33.8M | 37.4M | 50.3M | 37.9M | 39.8M | |
| Net Income | 79.7M | 84.6M | 96.1M | 105.4M | 108.5M | 114.0M | |
| Change In Cash | 11.4M | 18.9M | 18.7M | (36.7M) | (2.1M) | (2.0M) | |
| Other Non Cash Items | (146K) | 2.4M | (257K) | 1.7M | (5.0M) | (4.7M) | |
| Dividends Paid | 15.1M | 16.7M | 18.7M | 20.7M | 22.9M | 24.0M | |
| End Period Cash Flow | 65.7M | 84.6M | 103.2M | 66.6M | 64.4M | 46.2M | |
| Change To Netincome | 2.8M | 6.1M | 4.6M | 5.2M | 6.0M | 6.3M | |
| Change Receivables | 11.6M | (3.6M) | (20.7M) | (3.6M) | (3.3M) | (3.4M) | |
| Net Borrowings | 75.0M | (85M) | (55.2M) | 299.8M | 344.7M | 362.0M | |
| Investments | (1M) | (850K) | (35.3M) | (150K) | (37.4M) | (39.3M) |
Balchem Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Balchem or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Balchem's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Balchem stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 1.23 | |
σ | Overall volatility | 1.44 | |
Ir | Information ratio | 0.01 |
Balchem Volatility Alert
Balchem has relatively low volatility with skewness of 0.31 and kurtosis of 0.93. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Balchem's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Balchem's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Balchem Fundamentals Vs Peers
Comparing Balchem's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Balchem's direct or indirect competition across all of the common fundamentals between Balchem and the related equities. This way, we can detect undervalued stocks with similar characteristics as Balchem or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Balchem's fundamental indicators could also be used in its relative valuation, which is a method of valuing Balchem by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Balchem to competition |
| Fundamentals | Balchem | Peer Average |
| Return On Equity | 0.11 | -0.31 |
| Return On Asset | 0.0642 | -0.14 |
| Profit Margin | 0.13 % | (1.27) % |
| Operating Margin | 0.20 % | (5.51) % |
| Current Valuation | 5.96 B | 16.62 B |
| Shares Outstanding | 32.51 M | 571.82 M |
| Shares Owned By Insiders | 0.46 % | 10.09 % |
| Shares Owned By Institutions | 90.81 % | 39.21 % |
| Number Of Shares Shorted | 442.21 K | 4.71 M |
| Price To Earning | 42.37 X | 28.72 X |
| Price To Book | 4.92 X | 9.51 X |
| Price To Sales | 6.14 X | 11.42 X |
| Revenue | 922.44 M | 9.43 B |
| Gross Profit | 280.45 M | 27.38 B |
| EBITDA | 215.4 M | 3.9 B |
| Net Income | 108.54 M | 570.98 M |
| Cash And Equivalents | 58.1 M | 2.7 B |
| Cash Per Share | 1.81 X | 5.01 X |
| Total Debt | 330.33 M | 5.32 B |
| Debt To Equity | 0.53 % | 48.70 % |
| Current Ratio | 2.59 X | 2.16 X |
| Book Value Per Share | 36.21 X | 1.93 K |
| Cash Flow From Operations | 183.76 M | 971.22 M |
| Short Ratio | 4.46 X | 4.00 X |
| Earnings Per Share | 3.74 X | 3.12 X |
| Price To Earnings To Growth | 4.79 X | 4.89 X |
| Target Price | 190.33 | |
| Number Of Employees | 1.3 K | 18.84 K |
| Beta | 0.65 | -0.15 |
| Market Capitalization | 5.79 B | 19.03 B |
| Total Asset | 1.6 B | 29.47 B |
| Retained Earnings | 897.49 M | 9.33 B |
| Working Capital | 165.75 M | 1.48 B |
Note: Disposition of 00 shares by Backus William A. of Balchem at 84.09 subject to Rule 16b-3 [view details]
Balchem Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Balchem . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Balchem Buy or Sell Advice
When is the right time to buy or sell Balchem? Buying financial instruments such as Balchem Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Balchem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Candy and Soda Thematic Idea Now
Candy and Soda
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Candy and Soda theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Candy and Soda Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Balchem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Dividend Share 0.79 | Earnings Share 3.74 | Revenue Per Share 29.208 | Quarterly Revenue Growth 0.043 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.